ArticleEuropean journal of clinical pharmacology2024

Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study.

Xinhai Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.